Vicore Pharma postpones publication of year-end report

2019-02-13 | Regulatory

Mölndal, February 13, 2019 – Vicore Pharma Holding AB (publ) has decided to postpone the publication of the year-end report for 2018. The year-end report will be published on March 15, 2019, instead of previously announced February 22, 2019.

The reason for postponing the report is the decision to convert the company’s accounting principles to IFRS as per the year-end report for 2018. Conversion to IFRS is an important part of the preparations for the up-listing to the Stockholm Nasdaq main list which is planned to take place during the second half of 2019.

For further information, please contact:

Hans Jeppsson, CFO: +46 70 553 14 65,